Here goes Howard.....Back peddle Back peddleAnd of course they have stretched out the milestones once again. Unbelievable.
https://www.sironabiochem.com/wp-content/uploads/2021/05/SBM-Investor-Presentation-May2021.pdf
Sirona anticipates achieving the following milestones • within the next 3 months: • Finalize due diligence and agree on terms with new organization in China • Complete an additional licensing agreement for the SGLT2 inhibitor in new markets • Secure non-dilutive funding through anticipated collaborations • Finalize Tinyi agreement • Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II •
within the next 6 months: • Scale-up batch of lead anti-aging compound • Complete safety studies for anti-aging compound in preparation for clinical study •
within the next 12 months: • Enter clinical trial for anti-wrinkle compound • Develop new anti-viral compounds and advance them into preclinical studies